Concepedia

James T. Alston

JT

Statistics

Publications

15

Citations

1.3K

H-Index

14

Active since

1989

Affiliations

Eli Lilly (United States)(Current)

Pfizer (United States)

University of Calgary

James T. Alston is an author at Eli Lilly (United States) specializing in life sciences, medicine, and molecular biology.

Publications per year

1989–2018

15

Publications

15

Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS‐4 and ADAMTS‐5

Ruo-Hua Song, Micky D. Tortorella, Anne‐Marie Malfait et al. · Arthritis & Rheumatism · 2007 · 403 citations

, , +17

Cloning, Expression, and Pharmacological Characterization of a Novel Human Histamine Receptor

Yuan Zhu, David Michalovich, Hsiao-Ling Wu et al. · Molecular Pharmacology · 2001 · 313 citations · Full text

, , +13

High Molecular Weight Polyethylene Glycol Cellular Distribution and PEG-associated Cytoplasmic Vacuolation Is Molecular Weight Dependent and Does Not Require Conjugation to Proteins

Daniel G. Rudmann, James T. Alston, Jeffrey C. Hanson et al. · Toxicologic Pathology · 2013 · 166 citations · Full text

, , +15

Proprotein convertase activation of aggrecanases in cartilage in situ

Anne‐Marie Malfait, Elizabeth C. Arner, Ruo-Hua Song et al. · Archives of Biochemistry and Biophysics · 2008 · 69 citations

, , +12

ADAM‐8 isolated from human osteoarthritic chondrocytes cleaves fibronectin at Ala<sup>271</sup>

Marc D. Zack, Anne‐Marie Malfait, Adam Skepner et al. · Arthritis & Rheumatism · 2009 · 50 citations

, , +17

1–5 of 15